Narihisa Miyachi
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Ethnic sensitivity analyses of pharmacokinetics, efficacy and safety in polycythemia vera treatment with ropeginterferon alfa-2b.
Journal: Frontiers in pharmacology
Published: June 27, 2024
Correction to: Efficacy and safety of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: an open-label, single-arm, phase 2 study.
Journal: International journal of hematology
Published: August 27, 2022
Efficacy and safety of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: an open-label, single-arm, phase 2 study.
Journal: International journal of hematology
Published: January 09, 2022
Pharmacokinetics and Pharmacodynamics of Ropeginterferon Alfa-2b in Healthy Japanese and Caucasian Subjects After Single Subcutaneous Administration.
Journal: Clinical drug investigation
Published: March 06, 2021
Impaired psychomotor vigilance associated with sleep-disordered breathing in women working in the care of older adults in Japan.
Journal: Sleep & breathing = Schlaf & Atmung
Published: December 15, 2020
Proposal of Standard for Medical Science Liaison (MSL) Profession in Japan: A Viewpoint from the Japanese Association of Pharmaceutical Medicine (JAPhMed).
Journal: Pharmaceutical medicine
Published: October 08, 2020
Prevalence of sleep-disordered breathing among women working in the aged care services in Japan.
Journal: International archives of occupational and environmental health
Published: October 11, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026